Literature DB >> 15218543

The role of labile iron pool in cardiovascular diseases.

Marcin Kruszewski1.   

Abstract

Although multiple factors are associated with cardiovascular pathology, there is now an impressive body of evidence that free radicals and nonradical oxidants might cause a number of cardiovascular dysfunctions. Both direct damage to cellular components and/or oxidation of extracellular biomolecules, e.g. LDL, might be involved in the aetiology of cardiovascular diseases. The key molecules in this process seem to be iron and copper ions that catalyse formation of the highly reactive hydroxyl radical. Chelation of iron ions has a beneficial effect on the processes associated with the development of atherosclerosis and formation of post-ischemic lesions. These findings are indirectly supported by the increasing body of evidence that stored body iron plays a crucial role in pathogenesis of atherosclerosis and ischemia/reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15218543     DOI: 035001471

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  28 in total

1.  Metal chelator combined with permeability enhancer ameliorates oxidative stress-associated neurodegeneration in rat eyes with elevated intraocular pressure.

Authors:  P Liu; M Zhang; M Shoeb; D Hogan; Luosheng Tang; M F Syed; C Z Wang; G A Campbell; N H Ansari
Journal:  Free Radic Biol Med       Date:  2014-02-06       Impact factor: 7.376

2.  Cardioprotective effects of iron chelator HAPI and ROS-activated boronate prochelator BHAPI against catecholamine-induced oxidative cellular injury.

Authors:  Pavlína Hašková; Hana Jansová; Jan Bureš; Miloslav Macháček; Anna Jirkovská; Katherine J Franz; Petra Kovaříková; Tomáš Šimůnek
Journal:  Toxicology       Date:  2016-10-12       Impact factor: 4.221

3.  A kinetic approach to assess oxidative metabolism related features in the bivalve Mya arenaria.

Authors:  Paula Mariela González; Doris Abele; Susana Puntarulo
Journal:  Theory Biosci       Date:  2012-07-25       Impact factor: 1.919

4.  Iron mediates N-methyl-D-aspartate receptor-dependent stimulation of calcium-induced pathways and hippocampal synaptic plasticity.

Authors:  Pablo Muñoz; Alexis Humeres; Claudio Elgueta; Alfredo Kirkwood; Cecilia Hidalgo; Marco T Núñez
Journal:  J Biol Chem       Date:  2011-02-04       Impact factor: 5.157

5.  Effect of bicarbonate on iron-mediated oxidation of low-density lipoprotein.

Authors:  Hirofumi Arai; Barbara S Berlett; P Boon Chock; Earl R Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-18       Impact factor: 11.205

6.  Iron chelation therapy in myelodysplastic syndromes.

Authors:  Emanuela Messa; Daniela Cilloni; Giuseppe Saglio
Journal:  Adv Hematol       Date:  2010-06-20

7.  Changes in copper and zinc status and response to dietary copper deficiency in metallothionein-overexpressing transgenic mouse heart.

Authors:  Y James Kang; Youchun Jiang; Jack T Saari
Journal:  J Nutr Biochem       Date:  2007-08-17       Impact factor: 6.048

Review 8.  Iron deficiency anemia in heart failure.

Authors:  Natasha P Arora; Jalal K Ghali
Journal:  Heart Fail Rev       Date:  2013-07       Impact factor: 4.214

9.  Mouse Models of Oxidative Stress Indicate a Role for Modulating Healthy Aging.

Authors:  Ryan T Hamilton; Michael E Walsh; Holly Van Remmen
Journal:  J Clin Exp Pathol       Date:  2012-06-20

10.  Update on the use of deferasirox in the management of iron overload.

Authors:  Ali Taher; Maria Domenica Cappellini
Journal:  Ther Clin Risk Manag       Date:  2009-11-02       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.